You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ACE-536

Showing 1 - 25 of 545
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Beta-thalassemia Trial in Nanning (Luspatercept, Placebo)

Recruiting
  • Beta-thalassemia
  • Nanning, China
  • +1 more
Jan 13, 2023

Anemia Trial (Luspatercept)

Not yet recruiting
  • Anemia
  • Luspatercept
  • (no location specified)
May 26, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Anemia Trial in Worldwide (biological, drug, other)

Recruiting
  • Anemia
  • Luspatercept
  • +2 more
  • Halifax, Nova Scotia, Canada
  • +11 more
Jan 3, 2023

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

MDS Trial in Dresden (ACE-536)

Completed
  • Myelodysplastic Syndromes
  • ACE-536
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

Anemia Trial in Dresden (ACE-536)

Completed
  • Anemia
  • ACE-536
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

Beta-Thalassemia Trial in Greece, Italy (ACE-536)

Completed
  • Beta-Thalassemia
  • ACE-536
  • Athens, Greece
  • +6 more
May 17, 2021

Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))

Active, not recruiting
Has Results
  • Thalassemia
  • Los Angeles, California
  • +16 more
Aug 16, 2022

MDS Trial in China, Japan (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
  • +33 more
Aug 16, 2022

MDS Trial in United States (Lenalidomide, Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
Sep 28, 2022

MDS Trial in Worldwide (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Los Alamitos, California
  • +53 more
Sep 13, 2023

Erythrocyte Transfusion, Beta-Thalassemia Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Erythrocyte Transfusion
  • Beta-Thalassemia
  • Los Angeles, California
  • +72 more
Jan 21, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • Luspatercept Injection [Reblozyl]
  • Eprex
  • Amiens, France
  • +30 more
May 19, 2022

Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

Completed
  • Primary Myelofibrosis
  • Anemia
  • Phoenix, Arizona
  • +24 more
Aug 17, 2022

MDS (MDS), Beta-thalassemia, Myeloproliferative Tumor(MPN)-Associated Myelofibrosis Trial in Worldwide (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Los Angeles, California
  • +203 more
Jan 30, 2023

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • ACE-536
  • Placebo
  • La Jolla, California
  • +184 more
Aug 22, 2022

MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Luspatercept Injection [Reblozyl]
  • Alessandria, Italy
  • +22 more
Jun 20, 2023

MDS Trial in Beijing (Roxadustat, Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 17, 2023

Keloid Scar Trial (Intralesional enalaprilat injection)

Not yet recruiting
  • Keloid Scar
  • Intralesional enalaprilat injection
  • (no location specified)
Jun 8, 2022

Minimisation Measures for REBLOZYL Among Healthcare

Active, not recruiting
  • Myelodysplastic Syndromes
  • Beta-thalassemia
    • City, State, Austria
      Local Institution
    Aug 4, 2022

    Hypertension Trial in Japan (TAK-536)

    Recruiting
    • Hypertension
    • Nagoya, Aichi, Japan
    • +18 more
    Jul 7, 2022